IBCN annual meeting included a bladder cancer session, featuring a presentation by Dr. Amanda Myers discussing the ...
IBCN annual meeting included a keynote lecture by Dr. Niko Beerenwinkel discussing inferring tumor evolution from single-cell data. Although the majority of work has been done in other cancers (ie.
IBCN 2024: Oncolytic Virotherapy Expressing a Novel TLR Agonist and IL-15 for the Treatment of NMIBC
In vivo, using the subcutaneous MB49 bladder cancer model, HSV5-15 virus expressing both the cytokine and TLR agonist ...
IBCN annual meeting included a session on novel therapies and outcome measures in clinical trials, featuring a presentation by Dr. Gautier Marcq discussing the benefit of whole-pelvis radiation for ...
(UroToday.com) The 2024 IBCN annual meeting included a session on molecular subtyping in the 2024, featuring a presentation by Dr. Saum Ghodoussipour discussing the LUMBER-NAC trial in progress. A ...
Undetectable pre-cystectomy ctDNA predicts better pathological outcomes post-radical cystectomy Patients with undetectable pre-cystectomy status demonstrated recurrence-free survival, regardless of ...
(UroToday.com) The 2024 IBCN annual meeting included a session on advancements in circulating biomarkers, featuring a presentation by Dr. Priyanka Yolmo discussing BCG-induced B cell responses in ...
(UroToday.com) The 2024 IBCN annual meeting included a session on preclinical models and genomic insights, featuring a presentation by Dr. Philippe Lamy discussing the comprehensive genomic ...
Reno, Nevada (UroToday.com) -- Phreesia, a leader in patient intake, outreach and activation, together with the National Association For Continence (NAFC), Health.Equity.Outcomes. and Christina ...
Tissue studies have confirmed 5-ARIs induce >90% decreases in intraprostatic DHT levels. 7,8 This decline is nearly identical to that observed after androgen deprivation therapy (ADT) with a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback